Latin America Therapeutic Vaccines Market By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
Latin America Therapeutic Vaccines Market By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
ID: 78 | Pages: 138 | October 2018 | Region: Latin America
Latin America Therapeutic Vaccines Market which is poised to reach $361.06 Million in 2023, from the current value of $1618.98 Million in 2018 with a CAGR of 35% Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. Added to this the vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.
Coming to Latin America Sanofi Pasteur, the vaccines division of Sanofi, announced that Brazil has granted regulatory approval to Dengvaxia®, representing the third successful licensure of the dengue vaccine, which was also approved in Mexico and the Philippines earlier in 2015. This in the light of the fact that Brazil being the fifth most populated in world and first in Latin America is plagued by 1.4 million dengue patients. The remaining countries in Latin America also have a natural threat as they lie in the tropical amazon basin which makes them a hotbed for various epidemics.
Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.
By types of disease, the Latin America Therapeutic Vaccines Market is segmented into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, on the basis of geography, it is segmented and analysed at a country level including Brazil, Argentina and Mexico.
Some of the key industry leaders that have been operating in Latin America are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.
- Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
- Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
- Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
- Market Segmentation
5.1 By Disease Type
5.1.1 Autoimmune Disease Vaccines
5.1.2 Cancer Vaccines
5.1.2.1 Multikine
5.1.2.2 PR1 Peptide
5.1.2.3 TroVax
5.1.2.4 CYT004-MelQbG10
5.1.3 Neurological Disease Vaccines
5.1.3.1 ACC- 001
5.1.3.2 CAD 106
5.1.3.3 Parkinson's Disease Vaccine
5.1.3.4 Alzheimer's Disease
5.1.4 Infectious Disease Vaccines
5.1.4.1 Hepatitis C
5.1.4.2 HIV/AIDS
5.1.4.3 Other Infectious Disease
- Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Argentina
6.4 Mexico
- Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
- Market Leaders' Analysis
8.1 GlaxoSMithKline plc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Merck and Company
8.3 Bavarian Nordic
8.4 CSL Limited
8.5 Emergent Biosolutions Inc.
8.6 Novartis AG
8.7 Johnson and Johnson
8.8 MedImmune LLC
8.9 Pfizer Inc.
8.10 Sanofi Pasteur
- Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
- Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
- List of Tables
- List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
| Title | Price | Add To Cart |
- Latin America Therapeutic Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Million )
- Latin America Autoimmune Disease Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America Cancer Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America Neurological Disease Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America Infectious Disease Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America Cancer Vaccines Market By Type, From 2018-2023 ( USD Million )
- Latin America Multikine Market By Region, From 2018-2023 ( USD Million )
- Latin America PR1 Peptide Market By Region, From 2018-2023 ( USD Million )
- Latin America TroVax Market By Region, From 2018-2023 ( USD Million )
- Latin America CYT004-MelQbG10 Market By Region, From 2018-2023 ( USD Million )
- Latin America Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Latin America ACC- 001 Market By Region, From 2018-2023 ( USD Million )
- Latin America CAD 106 Market By Region, From 2018-2023 ( USD Million )
- Latin America Parkinson's Vaccine Market By Region, From 2018-2023 ( USD Million )
- Latin America Alzheimer's Vaccine Market By Region, From 2018-2023 ( USD Million )
- Latin America Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Latin America Hepatitis C Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America HIV/AIDS Vaccines Market By Region, From 2018-2023 ( USD Million )
- Latin America Other Infectious Disease Vaccines Market By Region, From 2018-2023 ( USD Million )
- Brazil Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Million )
- Argentina Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Million )
- Mexico Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Million )
- Brazil Cancer Vaccines Market By Type, From 2018-2023 ( USD Million )
- Argentina Cancer Vaccines Market By Type, From 2018-2023 ( USD Million )
- Mexico Cancer Vaccines Market By Type, From 2018-2023 ( USD Million )
- Brazil Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Argentina Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Mexico Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Brazil Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Argentina Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
- Mexico Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Million )
Licence Type 
Clients
Why buy reports from Market Data Forecast
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues
Best Price guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance